CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, the leading sirtuin therapeutics company, announced today that it will be presenting at the MASS Opportunities Conference in Boston. Sirtris will discuss the Company’s strategy for discovering and developing first in class therapeutics that modulate sirtuins, a recently discovered family of enzymes that promote healthy cellular function. The presentation will be delivered at 1:50 EST on Thursday, November 2nd, 2006.
